SHARPE
Reported results
- Total sales volume was 583 Bcfe, inclusive of 21 Bcfe of strategic curtailments.
- Net income attributable to EQT was $279 million, and diluted income per share (EPS) was $0.44.
- Adjusted net income attributable to EQT (a non-GAAP financial measure) was $261 million, and Adjusted EPS (a non-GAAP financial measure) was $0.42.
- Net cash provided by operating activities was $1,083 million.
- Free cash flow attributable to EQT (a non-GAAP financial measure) was $283 million.
- Capital expenditures were $638 million.
Guidance
- For the fourth quarter of 2026, the Company expects total sales volume of 550 – 600 Bcfe, which includes the impact of 10 – 20 Bcfe of strategic curtailments.
- Fourth quarter 2026 maintenance capital expenditures are expected to be $540 – $610 million, and strategic growth capital expenditures are expected to total $185 – $225 million.
- Full year 2026 total sales volume is expected to be 2,375 – 2,450 Bcfe.
Price and volatility reaction
The stock moved -0.1% on the print. No front-expiry chain was on file, so there is no straddle expected move. 30-day ATM implied volatility moved -3.3 vol points across the event (constant-maturity series — not the front-week crush).
| Measure | Value | Basis |
|---|---|---|
| Close before release | 56.27 | 2026-10-27 |
| Close after release | 56.22 | 2026-10-28 |
| Realised move | -0.1% | close to close |
| 30d ATM IV change | -3.3 vol pts | constant-maturity series, not the front expiry |
Source
The figures above come from the earnings release the company filed with the SEC on 2026-10-27 (8-K, Item 2.02). Read the original filing on sec.gov.